Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Trisalus Life Sciences Inc (TLSI)

Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 370,733
  • Shares Outstanding, K 49,964
  • Annual Sales, $ 29,430 K
  • Annual Income, $ -30,050 K
  • EBIT $ -31 M
  • EBITDA $ -30 M
  • 60-Month Beta 0.43
  • Price/Sales 12.60
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.13
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +65.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.97 +49.95%
on 11/24/25
7.95 -6.16%
on 12/22/25
+2.39 (+47.14%)
since 11/21/25
3-Month
3.79 +96.83%
on 11/14/25
7.95 -6.16%
on 12/22/25
+2.58 (+52.87%)
since 09/22/25
52-Week
3.42 +118.13%
on 08/12/25
7.95 -6.16%
on 12/22/25
+3.41 (+84.20%)
since 12/20/24

Most Recent Stories

More News
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™

TriSalus Life Sciences, an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, is pleased to announce the launch...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance

TriSalus Reports $11.6 million i n Revenue, Up 57% Year-over-Year, Reflecting Strong Liver Embolization growth Investigator Published Data Show TriNav Enables...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences to Participate in Upcoming Investor Conferences

TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call

Conference Call and Webcast Scheduled for Thursday November 13, 2025 at 4:30 PM

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences to Participate in Upcoming September Investor Conferences

TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance

Company delivers $11.2M in revenues resulting in 52% growth year-over-year and 22% growth quarter-over-quarter Broadened PEDD portfolio...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique

TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for...

TLSI : 7.46 (+0.54%)
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference

TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), a company working to improve outcomes for patients with solid tumors by combining innovative drug delivery, today announced...

TLSI : 7.46 (+0.54%)

Business Summary

TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO.

See More

Key Turning Points

3rd Resistance Point 8.48
2nd Resistance Point 8.22
1st Resistance Point 7.84
Last Price 7.46
1st Support Level 7.19
2nd Support Level 6.93
3rd Support Level 6.55

See More

52-Week High 7.95
Last Price 7.46
Fibonacci 61.8% 6.22
Fibonacci 50% 5.68
Fibonacci 38.2% 5.15
52-Week Low 3.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar